Pineapple Express Cannabis (PNXP) Net Income towards Common Stockholders (2018 - 2025)
Pineapple Express Cannabis' (PNXP) quarterly Net Income towards Common Stockholders came in at $12121.0 in Q4 2025, up 1071.23% year-on-year from $1034.9 in Q4 2024, and up 103.49% quarter-over-quarter from -$346879.0 in Q3 2025.
Pineapple Express Cannabis (PNXP) Net Income towards Common Stockholders (2018 - 2025) Analysis & Trends
Pineapple Express Cannabis has disclosed Net Income towards Common Stockholders across 8 years of filings, most recently posting $12121.0 for Q4 2025.
- Net Income towards Common Stockholders for Q4 2025 came in at $12121.0, up 1071.23% year-over-year; the trailing twelve-month figure through Oct 2025 was -$678353.0 (up 31.81% YoY), and the FY2025 annual result was -$31153.0, up 47.64% from the prior year.
- Net Income towards Common Stockholders came in at $12121.0 for Q4 2025 at Pineapple Express Cannabis, up from -$346879.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $613913.0 in Q3 2023 to a low of -$994166.0 in Q1 2024.
- The 5-year median for Net Income towards Common Stockholders is -$2865.5 (2023), against an average of -$48922.2.
- Across the five-year window, Net Income towards Common Stockholders surged 45240.66% in 2023 and tumbled 8556.36% in 2025, its largest moves.
- Pineapple Express Cannabis' Net Income towards Common Stockholders stood at $1027.0 in 2021, then sank by 466.99% to -$3769.0 in 2022, then soared by 43.88% to -$2115.0 in 2023, then jumped by 40.99% to -$1248.0 in 2024, then surged by 1071.23% to $12121.0 in 2025.
- The last three Net Income towards Common Stockholders figures came in at $12121.0 (Q4 2025), -$346879.0 (Q3 2025), and -$313014.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 366.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 1.99 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Pineapple Express Cannabis | - | - | - | 12,121.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 12,121.00 |
| Jul 31, 2025 | -346,879.00 |
| Apr 30, 2025 | -313,014.00 |
| Jan 31, 2025 | -30,581.00 |
| Oct 31, 2024 | -1,248.00 |
| Jul 31, 2024 | 4,292.00 |
| Apr 30, 2024 | -3,616.00 |
| Jan 31, 2024 | -994,166.00 |
| Oct 31, 2023 | -2,115.00 |
| Jul 31, 2023 | 613,913.00 |
| Apr 30, 2023 | 179,594.00 |
| Jan 31, 2023 | -33,687.00 |
| Oct 31, 2022 | -3,769.00 |
| Jul 31, 2022 | -1,360.00 |
| Apr 30, 2022 | -5,627.00 |
| Jan 31, 2022 | -86,766.00 |
| Oct 31, 2021 | 1,027.00 |
| Jul 31, 2021 | 23,893.00 |
| Apr 30, 2021 | 15,763.00 |
| Jan 31, 2021 | -6,219.00 |